PXS 25
/ Syntara
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
March 18, 2023
"@drjkwan @PareshMalhotra https://t.co/ZyZApxs25i"
(@dr_shibley)
April 22, 2022
To Screen for Obstructive Sleep Apnoea in Type 2 Diabetes and its Correlation with Hscrp Levels and Microvascular Complications.
(PubMed, J Assoc Physicians India)
- "<img..."
Journal • Diabetes • Diabetic Neuropathy • Diabetic Retinopathy • Human Immunodeficiency Virus • Infectious Disease • Metabolic Disorders • Pain • Renal Disease • Respiratory Diseases • Retinal Disorders • Sleep Apnea • Sleep Disorder • Type 2 Diabetes Mellitus • CPOX • CRP • CUL4B • NLRP3 • PAK5
November 10, 2016
The effect of non-specific tight junction modulators on the transepithelial transport of poorly permeable drugs across airway epithelial cells.
(PubMed)
-
J Drug Target
- "It was also demonstrated that this reduction of TEER upon exposing the epithelial cells to the TJMs resulted in a significant increase in Flu-Na (Paracellular marker) and PXS25 (anti-fibrotic compound) transepithelial transport through this barrier. In conclusion, among the investigated non-specific TJMs, Na decanoate fulfilled the requirements of an effective, non-toxic and reversible tight junction modulator for Calu-3 lung epithelial cells."
Journal • Biosimilar
1 to 3
Of
3
Go to page
1